NEU 1.33% $20.73 neuren pharmaceuticals limited

$4.8bn US for x 4 indications in 2591+ % for upside in other...

  1. 2,150 Posts.
    lightbulb Created with Sketch. 513
    $4.8bn US for x 4 indications in 2591

    + % for upside in other potential indications given x 4 are successful and 2566 already commercial in x 1 and 2nd phase 2.

    + $2bn US minimum for 2566 licensing agreement in place, suitor picks this future cash flow up. (our 20% share + milestones)

    = $7-$8bn US valuation minimum for Neu based on this tool, approx in AUD $10.6bn - $12.2bn
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.73
Change
-0.280(1.33%)
Mkt cap ! $2.647B
Open High Low Value Volume
$20.87 $21.19 $20.70 $6.213M 297.7K

Buyers (Bids)

No. Vol. Price($)
4 5414 $20.72
 

Sellers (Offers)

Price($) Vol. No.
$20.79 335 1
View Market Depth
Last trade - 16.10pm 21/05/2024 (20 minute delay) ?
Last
$20.73
  Change
-0.280 ( 1.22 %)
Open High Low Volume
$20.99 $21.19 $20.69 94423
Last updated 15.59pm 21/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.